Purpose The aim of our study was to compare the diagnostic performance of 68 Ga-PSMA
PET and 99m Tc bone scintigraphy (BS) for the detection of bone metastases in prostate …

Purpose To investigate the added value and diagnostic accuracy of 68 Ga-PSMA PET/CT
versus bone scintigraphy (BS) for bone metastasis detection at the primary staging of …

Our purpose was to determine the relationship between serum prostate-specific antigen
(PSA) level categories (< 5, 5–10, 10–20, and> 20 ng/mL) and the incidence of bone …

Please see the Editorial Comment by Sungmin Woo discussing this article. BACKGROUND.
Bone scintigraphy (BS) using 99mTc-labeled methylene diphospho-nate (99mTc-MDP) …

Purpose 68 Ga ligands targeting prostate-specific membrane antigen (PSMA) are rapidly
emerging as a significant step forward in the management of prostate cancer. PSMA is a …

Purpose: Bone scintigraphy is the standard of reference in bone metastases in prostate
cancer patients. However, new radiotracers employed in prostate-specific membrane …

Abstract Purpose This study compared 68 Gallium-prostate-specific-membrane-antigen
based Positron-emission-tomography (68 Ga-PSMA-PET) and 99metastable technetium-3 …

Background 68Ga‐labelled prostate‐specific membrane antigen (PSMA) is a promising PET
ligand for the detection of prostate cancer. Little attention has been given to the ability of …

Objectives To determine the diagnostic accuracy of 68 gallium prostate-specific membrane
antigen (PSMA)-based positron emission tomography/computed tomography (PET/CT) in …

Purpose Uncertain focal bone uptake (UBU) with intensive radiopharmaceutical avidity are
frequently observed in patients undergoing [18F] PSMA-1007 PET/CT for the detection of …